Table 1 General characteristics of included meta-analysesa
Reference | Year | Country | Studies | Participants | Sex (F/M) | Cancer Types | Interventions | CRF Assessment |
|---|---|---|---|---|---|---|---|---|
Brown et al. [10] | 2011 | United States | 44 | 3254 | F/M | breast, colorectal, leukemia, lymphoma, prostate, mixed | AE and/or ST | BFI, EORTC-QLQ C30, FACT, FACT-An, FACT-B, FACT-F, FACT-G, LAS, PFS, POMS, SAS, SCFS, SF-36, 0–9 scale |
Carayol et al. [11] | 2013 | France | 11 | – | F | breast | AE and/or ST | BFI, FACT-F, MFI, PFS, SF-36(Vitality) |
Carayol et al. [12] | 2015 | France | 21 | 2181 | F | breast | AE and/or ST | SF-36(Vitality) |
Cramer et al. [13] | 2014 | Germany | 3 | 157 | F/M | colorectal | AE and/or ST | FACT-F |
Duijts et al. [16] | 2011 | Netherlands | 11 | 1244 | F | breast | AE and/or ST | FACT-F, FS, LAS-F, POMS, PFS, SCFS |
Fong et al. [17] | 2012 | China | 6 | 758 | F/M | breast, colon, colorectal, endometrial, gastric, gynecological, lung, lymphoma, testicular | AE and/or ST | EORTC-F, FACT-F, PFS |
Jacobsen et al. [18] | 2007 | United States | 12 | 833 | F/M | breast, colon, colorectal, multiple myeloma, prostate, mixed | AE and/or ST | – |
Kangas et al. [19] | 2008 | United States | 16 | 1001 | F/M | breast, colorectal, gastrointestinal, lung, myeloma, prostate, mixed | AE and/or ST | BFI, EORTC QLQ C30, FACIT-F, FACT-B, FACT-C, FACT-P/F, FACT-B/G, LAS-F, LASA fatigue/energy/anxiety/depression, PFS, PFS-R, POMS, POMS-F, POMS-SV, SAS-F, SF-36 |
Meneses-Echavez et al. [24] | 2015 | Colombia | 9 | – | F/M | breast, prostate, mixed | AE and/or ST | EORTC QLQ C30, FACT-B, FACT-F, FACT-G, FACT-P, PFS, SCFS |
Meneses-Echavez et al. [25] | 2015 | Colombia | 9 | 1016 | F | breast | AE and/or ST | EORTC QLQ C30, FACT-B, FACT-F, FACT-G, FACT-P, PFS, SCFS |
Meneses-Echavez et al. [26] | 2015 | Colombia | 11 | 1427 | F/M | breast, lymphoma, prostate | AE and/or ST | EORTC QLQ C30, FACT-B, FACT-F, FACT-G, FACT-P, PFS, SCFS |
Tian et al. [31] | 2016 | China | 26 | 2830 | F/M | breast, colorectal, gynecologic, hematological, nasopharyngeal prostate, other | AE | BFI, FACT-F, LASA, PFS, PFS-R, POMS |
Van Haren et al. [33] | 2013 | Netherlands | 2 | 115 | – | cancer patients undergoing hematopoietic stem cell transplantation | AE and/or ST | FACT-An, MFI, POMS-F |
Van Vulpen et al. [34] | 2016 | Netherlands | 3 | – | F/M | breast | AE and/or ST | FAQ, MFI-20 |
Velthuis et al. [35] | 2010 | Netherlands | 7 | 674 | F/M | acute myelogenous leukemia, breast, multiple myeloma, prostate | AE and/or ST | BFI, FACIT-F, FACT-An, FACT-F, PFS, PFS-R, POMS, SAS |
Zou et al. [36] | 2014 | China | 6 | 371 | – | breast | AE | FACIT-F, PFS-R |